ASSESSMENT OF HYPERTRIGLYCERIDEMIA ASSOCIATED RESIDUAL CARDIOVASCULAR RISK IN SECONDARY PREVENTION PATIENTS

被引：0
|
作者：
Gungor, B. [1 ]
Simsek, B. [1 ]
Cinar, T. [2 ]
Inan, D. [3 ]
Genc, D. [3 ]
Yumurtas, A. [1 ]
Vatanoglu, E. [4 ]
Yuksel, G. [5 ]
Karabay, C. [1 ]
机构：
[1] Univ Hlth Sci Dr Siyami Ersek Hosp, Cardiol, Istanbul, Turkiye
[2] Haydarpasa Sultan Abdulhamid Han Training & Res H, Cardiol, Istanbul, Turkiye
[3] Basak Basaksehir Cam & Sakura City Hosp, Cardiol, Istanbul, Turkiye
[4] Karadeniz Eregli State Hosp, Cardiol, Zonguldak, Turkiye
[5] Artvin State Hosp, Cardiol, Artvin, Turkiye
来源：
ATHEROSCLEROSIS | 2023年 / 379卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P443
引用
收藏
页码：S144 / S144
页数：1
相关论文
共 50 条
  • [31] Cardiovascular disease risk and secondary prevention of cardiovascular disease among patients with low health literacy
    van Schaik, T. M.
    Jorstad, H. T.
    Twickler, T. B.
    Peters, R. J. G.
    Tijssen, J. P. G.
    Essink-Bot, M. L.
    Fransen, M. P.
    NETHERLANDS HEART JOURNAL, 2017, 25 (7-8) : 446 - 454
  • [32] Cardiovascular disease risk and secondary prevention of cardiovascular disease among patients with low health literacy
    T. M. van Schaik
    H. T. Jørstad
    T. B. Twickler
    R. J. G. Peters
    J. P. G. Tijssen
    M. L. Essink-Bot
    M. P. Fransen
    Netherlands Heart Journal, 2017, 25 : 446 - 454
  • [33] Emphasis on prevention: how to approach residual cardiovascular risk
    J. H. Cornel
    R. J. G. Peters
    Netherlands Heart Journal, 2022, 30 : 1 - 2
  • [34] Hypertriglyceridemia and cardiovascular risk reduction
    Jacobson, Terry A.
    Miller, Michael
    Schaefer, Ernst J.
    CLINICAL THERAPEUTICS, 2007, 29 (05) : 763 - 777
  • [35] Emphasis on prevention: how to approach residual cardiovascular risk
    Cornel, J. H.
    Peters, R. J. G.
    NETHERLANDS HEART JOURNAL, 2022, 30 (01) : 1 - 2
  • [36] Hypertriglyceridemia as a cardiovascular risk factor
    Austin, MA
    Hokanson, JE
    Edwards, KL
    AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (4A): : 7B - 12B
  • [37] New cardiovascular prevention guidelines: How to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention?
    Atar, Dan
    Jukema, J. Wouter
    Molemans, Bart
    Taub, Pam R.
    Goto, Shinya
    Mach, Francois
    CerezoOlmos, Cesar
    Underberg, James
    Keech, Anthony
    Tokgozoglu, Lale
    Bonaca, Marc P.
    ATHEROSCLEROSIS, 2021, 319 : 51 - 61
  • [38] The Effects of Secondary Cardiovascular Prevention on Cancer Risk in Patients With Manifest Vascular Disease
    van Kruijsdijk, Rob C. M.
    van der Graaf, Yolanda
    Algra, Ale
    de Borst, Gert Jan
    Cramer, Maarten J.
    Siersema, Peter D.
    Peeters, Petra H. M.
    Visseren, Frank L. J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (23) : 2588 - 2589
  • [39] CARDIOVASCULAR RISK IN PATIENTS WITH TREATED FAMILIAL HYPERCHOLESTEROLEMIA AND PATIENTS WITH SEVERE HYPERTRIGLYCERIDEMIA
    MIKHAILIDIS, DP
    BARRADAS, MA
    DANDONA, P
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1987, 80 (01) : 61 - 61
  • [40] Risk profile of patients in a secondary cardiovascular prevention program: thrombotic versus hemorrhagic
    Sofia Jacinto, S.
    Eusebio, S.
    Soares, A.
    Viegas, J.
    Bras, P.
    Pack, T.
    Ferreira, T.
    Almeida Morais, L.
    Teixeira, B.
    Teixeira, R.
    Cruz Ferreira, R.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 566 - 566
12345